Engineered peptide-oligonucleotide composite nanotubes for redox-triggered drug delivery in cellular and pre-clinical glioma models.

Peptide-oligonucleotide complexes (POCs) represent a promising platform in targeted therapeutics, offering potential for drug delivery and gene therapy in complex diseases. This study focuses on the design, characterization, and anticancer applicatio…

Preview only. Read the full abstract at the source